The global Legionella water testing Market size was valued at USD 321 million in 2023 and is predicted to reach USD 577.1 million by 2030 with a CAGR of 8.7% from 2024-2030. Legionella water testing includes the diagnostic tools and methods for detecting legionella bacteria in various water systems.
These water quality testing solutions helps in preventing spread of legionnaires disease, that includes a severe form of pneumonia caused by inhaling water droplets contaminated with legionella bacteria.
The advantage of testing legionella lies in its ability to enhance public health protection, ensuring safety of water system, and ability to identify and mitigate contamination risks. These system helps various facilities of commercial, residential and industrial settings comply with stringent health and safety regulations, and foster safer environment for occupants.
The increasing prevalence of legionnaire disease increases the need for healthcare providers and regulatory bodies to mitigate the risk associated with severe respiratory disease that in turn boosts the legionella water testing market growth.
As per the report published by the World Health organization 2022, in Europe, Australia, and the U.S. there are about 10-15 cases of legionnaire disease are detected per million people annually. Among these reported cases, 75-80% are caused among individuals over the age of 50 years and 60-70% are male.
Legionella detection methods help in detecting and controlling the presence of legionella bacteria in water systems for preventing the outbreak of the disease. Consequently, the high prevalence of legionella disease necessitates the demand for water testing of legionella to identify and mitigate the outbreak of legionnaire disease.
Additionally, the implementation of stringent water testing regulations by regulatory bodies necessitates the need for regular monitoring and verification of water quality to prevent spread of water borne diseases such as legionnaires, thereby accelerating the legionella water testing market demand.
For instance, WHO guideline on water regulation emphasizes upon ensuring safe drinking water through regular monitoring and treatment of water to prevent contamination. The guideline stress on the need for rigorous testing of water quality to address potential hazards and protect public health from waterborne disease.
Compliance with such stringent regulation necessitates frequent and accurate testing of water systems to meet safety criteria, propelling the adoption of testing solution of legionella across various sectors.
Moreover, the surge in healthcare spending increases the investment of healthcare facilities in maintaining safety standards to protect patients from various diseases such as legionnaires that in turn accelerates the legionella water testing market growth.
The latest report of the World Bank Group states that global healthcare spending reached USD 1,266 per capita in 2021, marking an increase of approximately 7% from USD 1,180 per capita in 2020. Water treatment solutions are crucial for detecting contamination in water systems, thereby preventing legionnaires’ disease outbreaks and ensuring compliance with health and safety regulations.
The increase in healthcare budget enables hospitals and clinics to implement rigorous water management practices to ensure water system are free from harmful bacteria, thereby propelling the market growth.
However, the high cost of legionella water testing equipment and procedures restrains the legionella water testing market expansion by limiting access to advanced diagnostic tools particularly for smaller facilities with limited budget.
On the contrary, the introduction of mobile and portable testing units is expected to creates future opportunities for the market by enabling on-site, real-time detection, and analysis that enhances the flexibility and responsiveness of water safety management. This innovation is anticipated to expand testing of legionella in remote areas, improving overall monitoring capabilities and facilitating more widespread adoption of routine testing of legionella.
The legionella water testing market report is segmented on the basis of test type, application, end user and region. On the basis of test type, the market is divided into water testing, urine antigen testing (UAT), polymerase chain reaction (PCR), direct fluorescent antibody (DFA) test, and serology. On the basis of application, the market is categorized into clinical testing methods, environmental testing methods and others. On the basis of end user, the market is classified into hospitals & clinics, diagnostic laboratories, water treatment plants, and others. Regional breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.
North America dominates the legionella water testing market share and is projected to continue its dominance throughout the forecast period. This is attributed to the rise in healthcare spending by government in countries such as the U.S. and Canada that enables healthcare facilities to invest in safety measures and infrastructure such as testing of legionella.
The latest report of the Peter G. Foundation report states that the U.S. accounts for one of the highest healthcare costs globally, with spending reached USD 4.5 trillion in 2022, averaging USD 13,493 per person.
Testing of legionella helps in maintaining water safety by detecting the legionnaire bacteria that cause severe pneumonia among patients. The rise in government funding towards healthcare sector supports the implementation of comprehensive testing programs such as legionella water testing for protecting patients from the spread of legionnaire disease, thereby accelerating its demand in the region.
Additionally, the presence of government regulations aimed at preventing legionella disease in the region mandates regular monitoring and compliance measures to ensure water safety, that in turn drives the market growth.
For instance, the Canadian government implemented regulations to prevent legionnaires' disease by establishing stringent guidelines for the management and maintenance of water systems, including regular testing for legionella bacteria. These guidelines emphasize the need for effective control measures in facilities such as cooling towers and hot water systems to reduce the risk of outbreaks.
The implementation of such regulations towards preventing waterborne pathogens, accelerates the adoption of legionella water testing to meet legal standards, and protect public health.
On the other hand, Asia-Pacific is expected to show a steady rise in the legionella water testing market trends. This is due to the spread of water borne disease in the region that heightens the need for effective monitoring and control of water systems to prevent outbreaks that in turn propels the industry growth.
The latest report of the BioMed Central states that approximately 37.7 million Indians are affected by waterborne diseases each year, with an estimated 1.5 million children dying from diarrhea alone and 73 million working days lost annually due to these illnesses in 2022. Legionella bacteria thrive in warm, and stagnant water causing severe pneumonia. The rise of waterborne illness increases the pressure upon health agencies and regulatory bodies to ensure that water sources are free from harmful pathogens, thereby propelling the market growth.
Moreover, the implementation of stringent regulations for maintain water quality in the region further increases the demand for legionella bacteria testing by setting high standards for monitoring and controlling potential contaminants in water system. As per the latest report of the U.S. Department of Agriculture, Chinese government released a new national standard for drinking water quality, on March, 2022.
The updated standard introduces stricter limits on various contaminants, including bacteria and chemicals, aiming to improve public health and ensure safer drinking water across the country. Such regulatory standards increase the demand for legionella water testing by setting stricter limits on contaminants and requiring regular monitoring and maintenance of water quality, thus propelling the market growth in the region.
The legionella water testing industry comprising of various market players such as ChemREADY, QuidelOrtho Corporation, Phigenics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., BioMerieux Inc., Qiagen N.V., Albagaia Ltd., Aquacert Ltd., IDEXX Corporation, and others. These companies are adopting strategies such as product launches to stay competitive and maintain their market positions.
For instance, in May 2022, ChemREADY launched a new legionella water testing services and product program. This program allows customers to analyze and combat the water-borne pathogen through consulting, testing, legionella remediation, and secondary disinfection products in building water systems.
Moreover, in June 2021, Phigenics launched a new diagnostic, LegiPlex PCR (Polymerase Chain Reaction) to detect legionella serogroups and species in building water systems. This innovative diagnostic aimed to enhance the accuracy and efficiency of legionella detection, helping facilities better manage water safety and prevent outbreaks of legionnaires' disease.
The report provides quantitative analysis and estimations of the legionella water testing market from 2024 to 2030, which assists in identifying the prevailing industry opportunities.
The study comprises a deep-dive analysis of the current and future legionella water testing market trends to depict prevalent investment pockets in the sector.
Information related to key drivers, restraints, and opportunities and their impact on the market is provided in the report.
Competitive analysis of the players, along with their market share is provided in the report.
SWOT analysis and Porters Five Forces model is elaborated in the study.
Value chain analysis in the market study provides a clear picture of roles of stakeholders.
Water Testing
Urine Antigen Testing (UAT)
Polymerase Chain Reaction (PCR)
Direct Fluorescent Antibody (DFA) Test
Serology
Clinical Testing Methods
Environmental Testing Methods
Others
Hospitals & Clinics
Diagnostic Laboratories
Water Treatment Plants
Others
North America
The U.S.
Canada
Mexico
Europe
The UK
Germany
France
Italy
Spain
Denmark
Netherlands
Finland
Sweden
Norway
Russia
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Singapore
Taiwan
Thailand
Rest of Asia Pacific
RoW
Latin America
Middle East
Africa
ChemREADY
QuidelOrtho Corporation
Phigenics
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
BioMérieux Inc.
Qiagen N.V.
Albagaia Ltd.
Aquacert Ltd.
IDEXX Corporation
Parameters |
Details |
Market Size in 2023 |
USD 321.0 Million |
Revenue Forecast in 2030 |
USD 577.1 Million |
Growth Rate |
CAGR of 8.7% from 2024 to 2030 |
Analysis Period |
2023–2030 |
Base Year Considered |
2023 |
Forecast Period |
2024–2030 |
Market Size Estimation |
Million (USD) |
Growth Factors |
|
Countries Covered |
28 |
Companies Profiled |
10 |
Market Share |
Available for 10 companies |
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |